company

CYTOVATION ASA

5058 BERGEN

Return on Equity
−240,64 %
Current Ratio
3,82
Debt-to-Equity Ratio
0,21
Key figures (NOK)2022
Revenue0
Net Income−122 909 000
Total Assets83 918 000
Total Equity51 075 000
Income (NOK)2022
Revenue0
Expenditure122 064 000
Operating Profit−122 064 000
Financial Income1 557 000
Financial Costs2 402 000
Financial Balance−845 000
Earnings Before Tax−122 909 000
Tax0
Net Income−122 909 000
Balance (NOK)2022
Total Fixed Assets94 000
Total Current Assets83 823 000
Total Assets83 918 000
Total Retained Equity0
Total Equity51 075 000
Total Long-Term Debt10 906 000
Total Current Debt21 936 000
Total Equity and Debt83 918 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs2 697 000
Depreciation0
Impairment0
Expenditure122 064 000
Operating Profit−122 064 000
Financial Income1 557 000
Financial Costs2 402 000
Financial Balance−845 000
Dividends0
Net Income−122 909 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets94 000
Total Fixed Assets94 000
Stock0
Total Investments0
Cash, Bank78 967 000
Total Current Assets83 823 000
Total Assets83 918 000
Total Equity51 075 000
Short-Term Group Debt0
Total Long-Term Debt10 906 000
Creditors19 586 000
Unpaid Taxes291 000
Dividends0
Other Current Debt2 059 000
Total Current Debt21 936 000
Total Equity and Debt83 918 000
Financial indicators2022
Return on Equity−240,64 %
Debt-to-Equity Ratio0,21
Operating Profit Margin-
Current Ratio3,82
Quick Ratio3,82
Equity Ratio0,61
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English